Net profit of Epigral rose 12.45% to Rs 86.89 crore in the quarter ended March 2025 as against Rs 77.27 crore during the previous quarter ended March 2024. Sales rose 19.63% to Rs 627.63 crore in the quarter ended March 2025 as against Rs 524.63 crore during the previous quarter ended March 2024.
For the full year,net profit rose 82.62% to Rs 357.69 crore in the year ended March 2025 as against Rs 195.87 crore during the previous year ended March 2024. Sales rose 32.19% to Rs 2550.13 crore in the year ended March 2025 as against Rs 1929.19 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 627.63 | 524.63 | 20 | 2550.13 | 1929.19 | 32 |
| OPM % | 27.62 | 29.62 | - | 27.87 | 24.94 | - |
| PBDT | 165.28 | 143.83 | 15 | 673.65 | 414.31 | 63 |
| PBT | 131.33 | 113.45 | 16 | 541.09 | 290.75 | 86 |
| NP | 86.89 | 77.27 | 12 | 357.69 | 195.87 | 83 |